# Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension

> **NCT06933355** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Odense University Hospital** · enrollment: 8 (estimated)

## Conditions studied

- Kidney Transplantation Recipients
- Magnetic Resonance Imaging (MRI)
- Sodium-Glucose Transporter 2 Inhibitors
- Non-Diabetic Patients
- Randomized Controlled Trial
- Placebo Control Design

## Interventions

- **DRUG:** JARDIANCE 25mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06933355
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-27
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06933355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06933355, "Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06933355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*